In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SciClone Pharmaceuticals Inc.

www.sciclone.com

Latest From SciClone Pharmaceuticals Inc.

Deal Watch: Boehringer, Epizyme Team Up To Develop Epigenetic Cancer Therapies

BI and Epizyme’s collaboration will focus on developing novel cancer drugs targeting helicase and HAT enzyme dysregulation. MorphoSys and I-Mab will partner on developing an IO therapy targeting C5aR.

Deals Business Strategies

Crowdfunding Cancer Drug Development: Ability Pharma Hits Gold

At a time when attracting funding for small companies has become a tricky exercise, Spanish biotech has launched a crowdfunding round which is already proving successful.

Financing Cancer

Biopharma Quarterly Deal-Making Statistics, Q2 2017

Biopharma companies raised $13.4 billion in Q2, mostly through IPOs. Thanks to several billion-dollar deals in Q2, 2017 is shaping up to be a year of CRO consolidations. Big pharma continued divesting assets to smaller biopharma companies.

BioPharmaceutical Deals

China Investment Roundup: A Summer Of Cross-Border Transactions

It was a busy summer for Chinese pharmaceutical companies and investors who went global shopping, eying mega acquisition deals since China announced plans to accept overseas clinical trial data and global multicenter studies as part of its policies.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • SciClone Pharmaceuticals Inc.
  • Senior Management
  • Hong Zhao, CEO, China Ops.
    Lan Xie, VP Finance, CFO China Ops.
    Raymond A Low, VP Finance, Controller
  • Contact Info
  • SciClone Pharmaceuticals Inc.
    Phone: (650) 358-3456
    950 Tower Ln., Ste. 900
    Foster City, CA 94404-2125
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register